Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -269.47% is 10% above its 3-year average of -300.06%, around the middle of its 3-year range (-855.79%–0.00%).
56.46% below its 12-month average of -172.22%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -56.05%.
RETURN ON ASSETS (ROA)
-269.47%
RETURN ON ASSETS (ROA) AVG TTM
-172.22%
RETURN ON ASSETS (ROA) AVG 3Y
-300.06%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-56.46%
CURRENT VS 3Y AVG
+10.19%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-735.83%
vs the sector median at left
DataMEDS AI, Inc.
Market Cap
$8.51M
Return on Assets (ROA)
-269.47%
TTM Avg
-172.22%
3Y Avg
-300.06%
5Y Avg
N/A
Market Cap
$8.33M
Return on Assets (ROA)
-23.11%
TTM Avg
-173.03%
3Y Avg
-145.25%
5Y Avg
-97.33%
Market Cap
$8.23M
Return on Assets (ROA)
N/A
TTM Avg
-103.86%
3Y Avg
-117.64%
5Y Avg
-138.14%
Market Cap
$8.13M
Return on Assets (ROA)
-381.53%
TTM Avg
-330.40%
3Y Avg
-209.86%
5Y Avg
-253.27%
Market Cap
$7.85M
Return on Assets (ROA)
-29.10%
TTM Avg
-66.56%
3Y Avg
-142.45%
5Y Avg
-115.37%
Market Cap
$7.95M
Return on Assets (ROA)
-76.12%
TTM Avg
-177.28%
3Y Avg
-394.98%
5Y Avg
-300.85%
Market Cap
$9.00M
Return on Assets (ROA)
-6.36%
TTM Avg
-31.97%
3Y Avg
-31.64%
5Y Avg
-61.82%
Market Cap
$7.94M
Return on Assets (ROA)
86.37%
TTM Avg
-66.33%
3Y Avg
-66.09%
5Y Avg
-69.89%
Market Cap
$9.05M
Return on Assets (ROA)
-269.20%
TTM Avg
-150.53%
3Y Avg
-111.73%
5Y Avg
-102.54%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DataMEDS AI, Inc. (MEDS) | $8.51M | -269.47% | -172.22% | -300.06% | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -23.11% | -173.03% | -145.25% | -97.33% |
| HeartSciences Inc. (HSCS)vs › | $8.23M | N/A | -103.86% | -117.64% | -138.14% |
| GT Biopharma, Inc. (GTBP)vs › | $8.13M | -381.53% | -330.40% | -209.86% | -253.27% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.85M | -29.10% | -66.56% | -142.45% | -115.37% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.95M | -76.12% | -177.28% | -394.98% | -300.85% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.00M | -6.36% | -31.97% | -31.64% | -61.82% |
| Traws Pharma, Inc. (TRAW)vs › | $7.94M | 86.37% | -66.33% | -66.09% | -69.89% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.05M | -269.20% | -150.53% | -111.73% | -102.54% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.76M | -74.50% | -220.41% | -182.97% | -158.82% |
ROA
-269.5%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -332.49% |
| 2024-12-31 | -11.96% |
| 2023-12-31 | -855.79% |
| 2022-12-31 | 0.00% |
